Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins

Journal of Virology

Volumn 77, Issue 6, 2003, Pages 3878-3881

  Mullick, Jayati ^a   Bernet, John ^a   Singh, Akhilesh K ^a   Lambris, John D ^b   Sahu, Arvind ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KAPOSICA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; DISULFIDE BOND; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HYDROPHOBICITY; IMMUNE RESPONSE; INFECTION CONTROL; KAPOSI SARCOMA; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS CHARACTERIZATION;

CLONING, MOLECULAR; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATOR PROTEINS; GENE EXPRESSION REGULATION; HERPESVIRUS 8, HUMAN; HUMANS; OPEN READING FRAMES; PICHIA; VIRAL PROTEINS;

EID: 0037333485     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.6.3878-3881.2003     Document Type: Article

References (24)

1. Bernet, J., J. Mullick, A. K. Singh, and A. Sahu. Viral mimicry of the complement system. J. Biosci., in press.
2. Cooper, N. R. 1998. Complement and viruses, p. 393-407. In J. E. Volanakis and M. M. Frank (ed.), The human complement system in health and disease. Marcel Dekker, Inc., New York, N.Y.
3. Fodor, W. L., S. A. Rollins, S. Bianco-Caron, R. P. Rother, E. R. Guilmette, W. V. Burton, J. C. Albrecht, B. Fleckenstein, and S. P. Squinto. 1995. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 69:3889-3892.
4. Kapadia, S., B. Levine, S. Speck, and H. Virgin. 2002. Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 17:143-155.
5. Kapadia, S. B., H. Molina, V. van Berkel, S. H. Speck, and H. W. Virgin IV. 1999. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J. Virol. 73:7658-7670.
6. Kostavasil, I., A. Sahu, H. M. Friedman, R. J. Eisenberg, G. H. Cohen, and J. D. Lambris. 1997. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immunol. 158:1763-1771.
7. Kotwal, G. J., S. N. Isaacs, R. Mckenzie, M. M. Frank, and B. Moss. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827-830.
8. Lambris, J. D., A. Sahu, and R. Wetsel. 1998. The chemistry and biology of C3, C4, and C5, p. 83-118. In J. E. Volanakis and M. Frank (ed.), The human complement system in health and disease. Marcel Dekker, Inc., New York, N.Y.
9. Lubinski, J., T. Nagashunmugam, and H. M. Friedman. 1998. Viral interference with antibody and complement. Semin. Cell Dev. Biol. 9:329-337.
10. Mckenzie, R., G. J. Kotwal, B. Moss, C. H. Hammer, and M. M. Frank. 1992. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166:1245-1250.
11. Means, R. E., S. M. Lang, Y. H. Chung, and J. U. Jung. 2002. Kaposi's sarcoma associated herpesvirus immune evasion strategies. Front. Biosci. 7:e185-e203.
12. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87:3982-3986.
13. Rosengard, A. M., Y. Liu, Z. Nie, and R. Jimenez. 2002. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. USA 99:8808-8813.
14. Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93:14862-14867.
15. 1 inactivates the alternative complement pathway. J. Immunol. 160:5596-5604.
16. Sahu, A., and J. D. Lambris. 2001. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180:35-48.
17. Sahu, A., D. Morikis, and J. D. Lambris. 2000. Complement inhibitors targeting C3, C4, and C5, p. 75-112. In J. D. Lambris and V. M. Holers (ed.), Therapeutic interventions in the complement system. Humana Press Inc., Totowa, N.J.
18. Sahu, A., and M. K. Pangburn. 1993. Identification of multiple sites of interaction between heparin and the complement system. Mol. Immunol. 30:679-684.
19. Sahu, A., and M. K. Pangburn. 1996. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3. Biochem. Pharmacol. 51:797-804.
20. Smith, G. L., J. A. Symons, A. Khanna, A. Vanderplasschen, and A. Alcami. 1997. Vaccinia virus immune evasion. Immunol. Rev. 159:137-154.
21. Smith, S. A., N. P. Mullin, J. Parkinson, S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev, R. Srisatjaluk, D. N. Reynolds, K. L. Keeling, D. E. Justus, P. N. Barlow, and G. J. Kotwal. 2000. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74:5659-5666.
22. Spear, G. T., M. Hart, G. G. Olinger, F. B. Hashemi, and M. Saifuddin. 2001. The role of the complement system in virus infections. Curr. Top. Microbiol. Immunol. 260:229-245.
23. Stoiber, H., A. Clivio, and M. P. Dierich. 1997. Role of complement in HIV infection. Annu. Rev. Immunol. 15:649-674.
24. Vanderplasschen, A., E. Mathew, M. Hollinshead, R. B. Sim, and G. L. Smith. 1998. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. USA 95:7544-7549.